160 related articles for article (PubMed ID: 11442306)
1. Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?
Giacobini E
Aging (Milano); 2001 Jun; 13(3):247-54. PubMed ID: 11442306
[TBL] [Abstract][Full Text] [Related]
2. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer' disease.
Giacobini E
J Neural Transm Suppl; 2002; (62):181-7. PubMed ID: 12456062
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors stabilize Alzheimer's disease.
Giacobini E
Ann N Y Acad Sci; 2000; 920():321-7. PubMed ID: 11193171
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors stabilize Alzheimer disease.
Giacobini E
Neurochem Res; 2000 Oct; 25(9-10):1185-90. PubMed ID: 11059792
[TBL] [Abstract][Full Text] [Related]
6. Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?
Giacobini E
CNS Drugs; 2001; 15(2):85-91. PubMed ID: 11460892
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
Standridge JB
Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
[TBL] [Abstract][Full Text] [Related]
8. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
Lahiri DK; Rogers JT; Greig NH; Sambamurti K
Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501
[TBL] [Abstract][Full Text] [Related]
9. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
Parnetti L; Senin U; Mecocci P
Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
[TBL] [Abstract][Full Text] [Related]
10. From molecular structure to Alzheimer therapy.
Giacobini E
Jpn J Pharmacol; 1997 Jul; 74(3):225-41. PubMed ID: 9268083
[TBL] [Abstract][Full Text] [Related]
11. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer disease therapeutics.
Irizarry MC; Hyman BT
J Neuropathol Exp Neurol; 2001 Oct; 60(10):923-8. PubMed ID: 11589422
[TBL] [Abstract][Full Text] [Related]
13. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
15. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
16. PET studies and cholinergic therapy in Alzheimer's disease.
Nordberg A
Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
[TBL] [Abstract][Full Text] [Related]
17. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Wattmo C; Minthon L; Wallin ÅK
Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic foundations of Alzheimer's disease therapy.
Giacobini E
J Physiol Paris; 1998; 92(3-4):283-7. PubMed ID: 9789824
[TBL] [Abstract][Full Text] [Related]
19. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
20. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Martinez A; Castro A
Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
